Anti-MET (clone 5D5) Recombinant Antibody Coupled Liposome (VS-1024-FY38) (CAT#: VS-1024-FY38)

The strategy of using anti-MET antibody-conjugated liposomes represents a cutting-edge advancement in the treatment of lung cancer, offering a targeted approach to drug delivery. By attaching anti-MET antibodies to liposomes, this innovative method ensures that therapeutic agents are directed specifically to tumor cells that express the MET receptor, minimizing off-target effects. Consequently, this enhanced delivery system not only improves the efficacy of the treatment but also has the potential to reduce the side effects commonly associated with traditional chemotherapy.

Sub Cat Product Name Liposome Name Datasheet  
VS-1124-FY630 Anti-MET (clone 5D5) Recombinant Antibody Coupled Triptolide-loaded Liposome (VS-1124-FY630) Triptolide-loaded liposome
VS-1124-FY631 Anti-MET (clone 5D5) Recombinant Antibody Coupled Phospholipid Liposome and Cationic Liposome (VS-1124-FY631) Phospholipid liposome and Cationic liposome
VS-1124-FY632 Anti-MET (clone 5D5) Recombinant Antibody Coupled pH-sensitive Liposome (VS-1124-FY632) pH-sensitive liposome
VS-1124-FY633 Anti-MET (clone 5D5) Recombinant Antibody Coupled Magnetofluorescent Liposome (VS-1124-FY633) Magnetofluorescent liposome
VS-1124-FY634 Anti-MET (clone 5D5) Recombinant Antibody Coupled Phospholipid Liposome (VS-1124-FY634) Phospholipid liposome
VS-1124-FY635 Anti-MET (clone 5D5) Recombinant Antibody Coupled Cationic Liposome (VS-1124-FY635) Cationic liposome
VS-1124-FY636 Anti-MET (clone 5D5) Recombinant Antibody Coupled Gd-SLs Liposome (VS-1124-FY636) Gd-SLs liposome
VS-1124-FY637 Anti-MET (clone 5D5) Recombinant Antibody Coupled PEGylated Liposome (VS-1124-FY637) PEGylated liposome
VS-1124-FY638 Anti-MET (clone 5D5) Recombinant Antibody Coupled Adriamycin-encapsulated Liposome (VS-1124-FY638) Adriamycin-encapsulated liposome
VS-1124-FY639 Anti-MET (clone 5D5) Recombinant Antibody Coupled Phototoxic Liposome (VS-1124-FY639) Phototoxic liposome
VS-1124-FY640 Anti-MET (clone 5D5) Recombinant Antibody Coupled Targeted Liposome (VS-1124-FY640) Targeted Liposome
VS-1124-FY641 Anti-MET (clone 5D5) Recombinant Antibody Coupled Apt1-Liposome (VS-1124-FY641) Apt1-liposome
VS-1124-FY642 Anti-MET (clone 5D5) Recombinant Antibody Coupled Thermosensitive Liposome (VS-1124-FY642) Thermosensitive liposome
VS-1124-FY643 Anti-MET (clone 5D5) Recombinant Antibody Coupled Clodronate Liposome (VS-1124-FY643) Clodronate liposome
VS-1124-FY644 Anti-MET (clone 5D5) Recombinant Antibody Coupled Galcer Liposome (VS-1124-FY644) Galcer liposome
VS-1124-FY645 Anti-MET (clone 5D5) Recombinant Antibody Coupled HBsAg-loaded Liposome (VS-1124-FY645) HBsAg-loaded liposome
VS-1124-FY646 Anti-MET (clone 5D5) Recombinant Antibody Coupled ISMN Liposome (VS-1124-FY646) ISMN liposome
More Infomation
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
Normal Tissue
RNA Expression

Specifications

  • Potential Clinical Applications
  • Lung cancer

Product Composition

  • Clone
  • 5D5
  • Antibody Type
  • IgG
  • Antibody Host
  • Human
  • Antibody Reactivity
  • Human
  • Antibody Description
  • This product is a recombinant antibody derived from mice, specifically designed to target the MET protein. The MET protein, also known as the hepatocyte growth factor receptor (HGFR), plays a crucial role in various biological processes, including cell growth, motility, and differentiation. By binding to the MET protein, this antibody can be utilized for a wide range of research and therapeutic applications, including cancer studies, regenerative medicine, and the investigation of signaling pathways associated with MET.

Product Property

  • Storage
  • See in the COA
  • Storage Shelf Time
  • See in the COA

Target Information

  • Target
  • MET
  • Introduction
  • This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers.
  • Alternative Names
  • MET Proto-Oncogene, Receptor Tyrosine Kinase; Hepatocyte Growth Factor Receptor; Tyrosine-Protein Kinase Met; Scatter Factor Receptor; Proto-Oncogene C-Met; HGF/SF Receptor; HGF Receptor; SF Receptor; EC 2.7.10.1
  • Full Name
  • MET Proto-Oncogene, Receptor Tyrosine Kinase
  • Sequence Similarities
  • Belongs to the protein kinase superfamily. Tyr protein kinase family.
  • Cellular Localization
  • Membrane, Secreted
  • Post Translation Modifications
  • Autophosphorylated in response to ligand binding on Tyr-1234 and Tyr-1235 in the kinase domain leading to further phosphorylation of Tyr-1349 and Tyr-1356 in the C-terminal multifunctional docking site. Dephosphorylated by PTPRJ at Tyr-1349 and Tyr-1365. Dephosphorylated by PTPN1 and PTPN2.
    Ubiquitinated. Ubiquitination by CBL regulates MET endocytosis, resulting in decreasing plasma membrane receptor abundance, and in endosomal degradation and/or recycling of internalized receptors.
    (Microbial infection) Tyrosine phosphorylation is stimulated by L.monocytogenes InlB. Tyrosine phosphorylation is maximal 10-20 minutes after treatment with InlB and disappears by 60 minutes. The phosphorylated residues were not identified.
  • Function
  • Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of these downstream effectors by MET leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation is associated with the morphogenetic effects while PI3K/AKT coordinates prosurvival effects. During embryonic development, MET signaling plays a role in gastrulation, development and migration of muscles and neuronal precursors, angiogenesis and kidney formation. In adults, participates in wound healing as well as organ regeneration and tissue remodeling. Promotes also differentiation and proliferation of hematopoietic cells. May regulate cortical bone osteogenesis (By similarity).
    (Microbial infection) Acts as a receptor for Listeria monocytogenes internalin InlB, mediating entry of the pathogen into cells.

Related Resources

  • Related Diseases

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 5D5"

See other products for "MET"

Select a product category from the dropdown menu below to view related products.
Please select product type
Immunotoxin Products ADCC Enhanced Antibody Products ScFv Antibody Products Humanized Antibody Products Human Antibody Products Chimeric Antibody Products Mouse Antibody Products Neutralizing Antibody Products Rabbit Monoclonal Antibody Products Fab Antibody Products IgG Antibody Products MHC Tetramer Products for Cancer Non-Human Primate (NHP) Antibody Products ScFv-Fc Chimera Products IHC Kit and Antibody Products: Precision Tools for Immunohistochemistry Extracellular Vesicle (EV) Antibody Products
CAT Product Name Application Type
AGTO-G049E Anti-MET immunotoxin (Fab)-PE Cytotoxicity assay, Function study

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for VS-1024-FY38. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare